Analysis of the evolution of neurosurgical management and diagnostic methods with a genetic emphasis for Moyamoya Syndrome
DOI:
https://doi.org/10.33448/rsd-v11i4.27672Keywords:
Moyamoya; Cerebral Angiography; Diagnosis; Applications of epidemiology; Cerebral bleeding.Abstract
Introduction: Moyamoya syndrome or disease is a very rare cerebrovascular disorder that predisposes affected individuals to transient or permanent ischemic attacks due to progressive stenosis of the internal carotid artery and its branches, which causes compensatory responses, a large number of smaller blood vessels begins to grow and proliferate. Method: systematic literature review of the quantitative type using the following platforms: PubMed, SciELO, Google Scholar, Revista Brasileira de Neurocirurgia and Jornal Americano de Neurocirurgia. Results and Discussion: Catheter-based diagnostic cerebral angiography is the gold standard for obtaining a diagnosis. One study observed the presence of genetic expectations and concluded that females are the most affected in families (DMMs). Genome and locus-specific studies were performed by Kamada et al. (RNF213) was found as the first susceptibility gene for (DMM). Therefore, (p.R4859K) was recorded as the founder of the missense mutation in (RNF213), patients usually develop symptoms of (stroke) due to cerebral ischemia. Angiogenesis of collateral vessels within the basal ganglia can lead to dyskinesia. MRI enabled rapid detection of acute ischemic stroke using weighted imaging. Conclusion: Moyamoya syndrome is an occlusive cerebrovascular disease that has the potential to cause stroke, epilepsy and neurological dysfunction in adults and children. however, surgical intervention can prevent an upward progression of the disease.
References
Agarwalla, P. K., Stapleton, C. J., Phillips, M. T., Walcott, B. P., Venteicher, A. S., & Ogilvy, C. S. (2014). Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya. Journal of Neurosurgery, 121(6), 1394–1400. https://doi.org/10.3171/2014.8.jns132176
Ando, S., Tsutsui, S., Miyoshi, K., Sato, S., Yanagihara, W., Setta, K., Chiba, T., Fujiwara, S., Kobayashi, M., Yoshida, K., Kubo, Y., & Ogasawara, K. (2019). Cilostazol may improve cognition better than clopidogrel in non-surgical adult patients with ischemic moyamoya disease: subanalysis of a prospective cohort. Neurological Research, 41(5), 480–487.
Burke, G. M., Burke, A. M., Sherma, A. K., Hurley, M. C., Batjer, H. H., & Bendok, B. R. (2009). Moyamoya disease: a summary. Neurosurgical Focus, 26(4), E11.
Chiu, D., Shedden, P., Bratina, P., & Grotta, J. C. (1998). Clinical Features of Moyamoya Disease in the United States. Stroke, 29(7), 1347–1351.
Cho, H. J., Jung, Y. H., Kim, Y. D., Nam, H. S., Kim, D. S., & Heo, J. H. (2010). The different infarct patterns between adulthood-onset and childhood-onset moyamoya disease. Journal of Neurology, Neurosurgery & Psychiatry, 82(1), 38–40.
Deng, X., Zhang, D., Zhang, Y., Wang, R., Wang, B., & Zhao, J. (2017). Moyamoya disease with occlusion of bilateral vertebral arteries and the basilar artery fed by the collateral vessels of vertebral arteries: A rare case report. Journal of Clinical Neuroscience, 42, 116–118.
Fujimura, M., & Tominaga, T. (2015). Diagnosis of Moyamoya Disease: International Standard and Regional Differences. Neurologia Medico-Chirurgica, 55(3), 189–193.
Fujimura, M., Niizuma, K., Inoue, T., Sato, K., Endo, H., Shimizu, H., & Tominaga, T. (2013). Minocycline Prevents Focal Neurological Deterioration Due to Cerebral Hyperperfusion After Extracranial-Intracranial Bypass for Moyamoya Disease. Neurosurgery, 74(2), 163–170.
Fukui, M. (1997). Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (`Moyamoya’ disease). Clinical Neurology and Neurosurgery, 99, S238–S240.
Fukui, M., Kono, S., Sueishi, K., & Ikezaki, K. (2000). Moyamoya disease. Neuropathology, 20(s1), 61–64.
Fukuyama, Y., & Umezu, R. (1985). Clinical and cerebral angiographic evolutions of idiopathic progressive occlusive disease of the circle of willis (“Moyamoya” disease) in children. Brain and Development, 7(1), 21–37.
Hallemeier, C. L., Rich, K. M., Grubb, R. L., Chicoine, M. R., Moran, C. J., Cross, D. T., Zipfel, G. J., Dacey, R. G., & Derdeyn, C. P. (2006). Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon. Stroke, 37(6), 1490–1496.
Hishikawa, T., Sugiu, K., & Date, I. (2016). Moyamoya Disease: A Review of Clinical Research. Acta Medica Okayama, 70(4), 229–236.
Jang, D.-K., Huh, P. W., & Lee, K.-S. (2016). Association of apolipoprotein E gene polymorphism with small-vessel lesions and stroke type in moyamoya disease: a preliminary study. Journal of Neurosurgery, 124(6), 1738–1745.
Kamada, F., Aoki, Y., Narisawa, A., Abe, Y., Komatsuzaki, S., Kikuchi, A., Kanno, J., Niihori, T., Ono, M., Ishii, N., Owada, Y., Fujimura, M., Mashimo, Y., Suzuki, Y., Hata, A., Tsuchiya, S., Tominaga, T., Matsubara, Y., & Kure, S. (2010). A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. Journal of Human Genetics, 56(1), 34–40.
Khan, N., Dodd, R., Marks, M. P., Bell-Stephens, T., Vavao, J., & Steinberg, G. K. (2011). Failure of Primary Percutaneous Angioplasty and Stenting in the Prevention of Ischemia in Moyamoya Angiopathy. Cerebrovascular Diseases, 31(2), 147–153.
Kim, J. S. (2016). Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis. Journal of Stroke, 18(1), 2–11.
Kim, J-M., Lee, S-H., & Roh, J-K. (2008). Changing ischaemic lesion patterns in adult moyamoya disease. Journal of Neurology, Neurosurgery & Psychiatry, 80(1), 36–40.
Kuroda, S., & Houkin, K. (2008). Moyamoya disease: current concepts and future perspectives. The Lancet Neurology, 7(11), 1056–1066.
Lamônica, D. A. C., Ribeiro, C. da C., Ferraz, P. M. D. P., & Tabaquim, M. de L. M. (2016). Doença de Moyamoya: impacto no desempenho da linguagem oral e escrita. CoDAS, 28(5), 661–665.
Li, Q., Gao, Y., Xin, W., Zhou, Z., Rong, H., Qin, Y., Li, K., Zhou, Y., Wang, J., Xiong, J., Dong, X., Yang, M., Liu, Y., Shen, J., Wang, G., Song, A., & Zhang, J. (2019). Meta-Analysis of Prognosis of Different Treatments for Symptomatic Moyamoya Disease. World Neurosurgery, 127, 354–361.
Liao, X., Deng, J., Dai, W., Zhang, T., & Yan, J. (2017). Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review. Environmental Health and Preventive Medicine, 22(1).
Lira, C., Zanini, M., & Hamamoto Filho, P. (2017). Moyamoya Syndrome Manifesting with Choreiform Movements. Neuropediatrics, 49(01), 080–081.
Liu, W., Hitomi, T., Kobayashi, H., Harada, K. H., & Koizumi, A. (2012). Distribution of Moyamoya Disease Susceptibility Polymorphism p.R4810K in RNF213 in East and Southeast Asian Populations. Neurologia Medico-Chirurgica, 52(5), 299–303.
Maeda, M., & Tsuchida, C. (1999). “Ivy Sign” on Fluid-Attenuated Inversion-Recovery Images in Childhood Moyamoya Disease. American Journal of Neuroradiology, 20(10), 1836–1838.
Mikami, T., Suzuki, H., Komatsu, K., & Mikuni, N. (2019). Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease. Neurologia Medico-Chirurgica, 59(10), 361–370.
Miyatake, S., Touho, H., Miyake, N., Ohba, C., Doi, H., Saitsu, H., Taguri, M., Morita, S., & Matsumoto, N. (2012). Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity. Journal of Human Genetics, 57(12), 804–806.
Nanba, R., Kuroda, S., Ishikawa, T., Houkin, K., & Iwasaki, Y. (2004). Increased Expression of Hepatocyte Growth Factor in Cerebrospinal Fluid and Intracranial Artery in Moyamoya Disease. Stroke, 35(12), 2837–2842.
Ogawa, S., Ogata, T., Shimada, H., Abe, H., Katsuta, T., Fukuda, K., & Inoue, T. (2017). Acceleration of blood flow as an indicator of improved hemodynamics after indirect bypass surgery in Moyamoya disease. Clinical Neurology and Neurosurgery, 160, 92–95.
Qin, Y., Ogawa, T., Fujii, S., Shinohara, Y., Kitao, S., Miyoshi, F., Takasugi, M., Watanabe, T., & Kaminou, T. (2015). High incidence of asymptomatic cerebral microbleeds in patients with hemorrhagic onset-type moyamoya disease: a phase-sensitive MRI study and meta-analysis. Acta Radiologica, 56(3), 329–338.
Rafat, N., Beck, G. Ch., Peña-TapiaP. G., Schmiedek, P., & Vajkoczy, P. (2009). Increased Levels of Circulating Endothelial Progenitor Cells in Patients With Moyamoya Disease. Stroke, 40(2), 432–438.
Seol, H. J., Wang, K.-C., Kim, S.-K., Hwang, Y.-S., Kim, K. J., & Cho, B.-K. (2005). Headache in pediatric moyamoya disease: review of 204 consecutive cases. Journal of Neurosurgery: Pediatrics, 103(5), 439–442.
Smith, E. R., & Scott, R. M. (2012). Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. Journal of Neurosurgery: Pediatrics, 9(4), 353–360.
Starke, R. M., Komotar, R. J., & Connolly, E. S. (2009). Optimal surgical treatment for moyamoya disease in adults: direct versus indirect bypass. Neurosurgical Focus, 26(4), E8.
Takagi, Y., Kikuta, K., Nozaki, K., & Hashimoto, N. (2007). Histological Features of Middle Cerebral Arteries From Patients Treated for Moyamoya Disease. Neurologia Medico-Chirurgica, 47(1), 1–4.
Takagi, Y., Kikuta, K.-I., Sadamasa, N., Nozaki, K., & Hashimoto, N. (2006). Proliferative Activity through Extracellular Signal-regulated Kinase of Smooth Muscle Cells in Vascular Walls of Cerebral Arteriovenous Malformations. Neurosurgery, 58(4), 740–748.
Wouters, A., Smets, I., Van den Noortgate, W., Steinberg, G. K., & Lemmens, R. (2019). Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis. Acta Neurologica Belgica, 119(3), 305–313.
Yamashita, M., Tanaka, K., Matsuo, T., Yokoyama, K., Fujii, T., & Sakamoto, H. (1983). Cerebral dissecting aneurysms in patients with moyamoya disease. Journal of Neurosurgery, 58(1), 120–125.
Yao, Z., & You, C. (2018). Effect of surgery on the long-term functional outcome of moyamoya disease: a meta-analysis. Turkish Neurosurgery.
Yu, J., Shi, L., Guo, Y., Xu, B., & Xu, K. (2016). Progress on Complications of Direct Bypass for Moyamoya Disease. International Journal of Medical Sciences, 13(8), 578–587.
Zhang, H., Zheng, L., & Feng, L. (2019). Epidemiology, diagnosis and treatment of moyamoya disease (Review). Experimental and Therapeutic Medicine.
Zhao, J., Liu, H., Zou, Y., Zhang, W., & He, S. (2018). Clinical and angiographic outcomes after combined direct and indirect bypass in adult patients with moyamoya disease: A retrospective study of 76 procedures. Experimental and Therapeutic Medicine.
Zhao, M., Gao, F., Zhang, D., Wang, S., Zhang, Y., Wang, R., & Zhao, J. (2017). Altered expression of circular RNAs in Moyamoya disease. Journal of the Neurological Sciences, 381, 25–31.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 João Victor Carvalho da Paz; Elane Tavares Costa de Oliveira ; Janderson Saulnier Duque Bacelar Filho; Pedro Ricardo Primo Ferreira de Oliveira; Adrielle Luise Pereira Chagas ; Matheus Carreiro; Rebeca Silva de Melo; André Vinícius Reis Queiroga ; Blenda Michelle Eloi Bezerra Lima Sousa Barros ; Isabella Magalhães Assub; Julia Gomes Marques; Luís Carlos Correa Duarte Filho ; Itallo Romero Marques Sobreira; Mariana Moreno Rocha ; Camila Melo de Freitas
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
